Recent News

• 04.16.2025 - Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
• 04.16.2025 - Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
• 04.15.2025 - Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
• 04.15.2025 - Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
• 03.31.2025 - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.31.2025 - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.27.2025 - Vivani Medical Announces $8.25M Private Placement Equity Financing
• 03.27.2025 - Vivani Medical Announces $8.25M Private Placement Equity Financing
• 03.26.2025 - Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Recent Filings

• 04.15.2025 - 8-K Current report
• 04.15.2025 - EX-99.1 EX-99.1
• 04.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - 8-K Current report
• 03.27.2025 - 8-K Current report